Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Nnamdi Njoku Named President of Omnicell

including the launch of the Omnicell Titan XT automated dispensing system and expansion of the cloud-native OmniSphere platform. “Since joining Omnicell in 2024, Nnamdi has made a significant strategic impact on the Company, working to strengthen...

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

to help patients get authentic, FDA-approved medicines without having to turn to unsafe alternatives. For more information about the Medicare GLP-1 Bridge, patients are encouraged to speak with their healthcare professional. If you need support or...

Queue Secures $12.6 Million to Launch the World's First Fully Autonomous Robotic Pharmacy

building the world’s first fully autonomous robotic pharmacy, emerged from stealth with a working system designed to transform how prescriptions are dispensed, verified and delivered. The company recently closed an oversubscribed $12.6 million seed...

Avenacy Launched Norepinephrine Bitartrate Injection, USP in the U.S. Market

facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications. For more information, please visit www.avenacy.com.

Johnson & Johnson Strengthens European Cardiac Care with the Introduction of the Dual Energy THERMOCOOL SMARTTOUCH SF Ablation Platform

Johnson & Johnson announced the commercial launch of the Dual Energy THERMOCOOL SMARTTOUCH SF (DE STSF) Platform in Europe, expanding physician access to a dual-energy catheter ablation solution designed for personalized care across workflows,...

StatLab Introduces CytoPath Disc, Enhancing Global Standards in Cell Block Preparation

to traditional cell block methods, which convert concentrated cells suspended in fluid into a paraffin-embedded format for slide-based evaluation, the patent‑pending CytoPath Disc offers a more streamlined and efficient approach. The CytoPath Disc...

FDA Grants Approval to TRYNGOLZA® (olezarsen) for the Treatment of Severe Hypertriglyceridemia, Marking a First-in-Class Milestone

chief executive officer, Ionis. “TRYNGOLZA reflects the strength of Ionis’ innovative science and our commitment to transforming patients’ lives. As our first independent launch in a prevalent disease, this milestone builds on our success in...

FDA Grants Approval to TRYNGOLZA® (olezarsen) for the Treatment of Severe Hypertriglyceridemia, Marking a First-in-Class Milestone

chief executive officer, Ionis. “TRYNGOLZA reflects the strength of Ionis’ innovative science and our commitment to transforming patients’ lives. As our first independent launch in a prevalent disease, this milestone builds on our success in...

Zeta Surgical® has announced the successful treatment of the first patient using its Zeta TMS Navigation System at HOPE Therapeutics.

Cohen, Medical Director of HOPE Therapeutics, comments: "The continued evolution of precision TMS technology is transforming what's possible in psychiatric care. I am inspired by the increased accuracy, reliability and personalized care that these...

Upsher-Smith Expands KYMBEE™ (Deflazacort) Family of Products with Launch of Oral Suspension for the Treatment of Duchenne Muscular Dystrophy

BCPS, BCMAS, Medical Affairs Director, Upsher-Smith. "With KYMBEE™ (deflazacort) now available in both tablet and liquid formulations, we offer options to help meet the needs of patients and caregivers, including children who may have difficulty...

Strong Performance Across More Than 200 Customer Audits Highlighted by Piramal Pharma Solutions

strategy combines robust governance, quality culture, workforce development, process harmonization, and digital transformation to support sustained compliance, continuous audit readiness, and operational effectiveness. This approach helps the...

Cryo-EM Collaboration Between Gandeeva and Zymeworks Speeds Antibody Drug Discovery

interfaces at high resolution. While cryo-EM is now used routinely to determine structures of antibody complexes formed with compact and well-folded antigens, mapping antibody epitope footprints on small and flexible antigens remains highly...

CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Receives U.S. FDA Approval for an Additional Indication in Children and Adolescents Aged 2–17 Years at Increased Risk for Pneumococcal Disease

reaction (e.g., anaphylaxis) to any component of CAPVAXIVE or to diphtheria toxoid; see additional Select Safety Information below. The indication for the prevention of pneumonia caused by S. pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F,...

Avenacy Announces the U.S. Launch of Bortezomib for Injection

facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications. For more information please visit, www.avenacy.com

WISE Closes Oversubscribed €30 Million Series D Financing Round with ENEA Tech and Biomedical Joining as Strategic Investor

while also driving the commercial scale-up of WISE's full electrode portfolio across target markets. A Differentiated Platform for Next-Generation Neurotechnology WISE's proprietary Supersonic Technology enables the production of implantable...

Rugiet Launched Physician-Prescribed Peptide and Longevity Therapies, Setting a New Standard in Performance Medicine

Rugiet, the performance medicine company that’s helped more than 500,000 men take control of their health, announced the expansion of its treatment areas to include longevity. Rugiet is bringing its physician-prescribed standards to an emerging...

Bayer’s AMBELVIST® (gadoquatrane) Gains FDA Approval for Contrast-Enhanced MRI in Detection of Lesions with Abnormal Vascularity Across CNS and Non-CNS Body Regions

human body. This type of study can play an important role in detecting abnormalities, monitoring disease progression and informing treatment decisions.3 For some adults and children with chronic diseases or conditions that require close, long-term...

EVERY and Huvepharma Announce Fourfold Expansion of Production Capacity

is a direct response to the market’s clear signal: the food industry is ready for egg proteins that deliver parity on performance without the supply chain challenges endemic in the global egg supply chain." The expanded production will primarily...

Results from Incyte’s Phase 3 frontMIND Trial of Tafasitamab Combination Show Prolonged Progression-Free Survival Presented at EHA 2026

of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation & Autoimmunity. For more information please visit, www.Incyte.com

DIA Global Annual Meeting

Day: Celebrate breakthroughs and emerging players shaping the next generation of therapies. And More to Come: Fresh formats, dynamic networking experiences, and unique ways to connect across disciplines. Be part of the next chapter in life...